Long‐term exposure to the new nicotinic antagonist 1,2‐bis<i>N</i>‐cytisinylethane upregulates nicotinic receptor subtypes of SH‐SY5Y human neuroblastoma cells

Loredana Riganti(University of Milan), Cecilia Gotti(University of Milan)
British Journal of Pharmacology
November 7, 2005
Cited by 26


Related Papers